CDK4 and neoplasm: In the first situation, recall that cyclin D-CDK4/6 and cyclin E-CDK2 kinase complexes phosphorylate and inactivate the RB1 tumor suppressor during the G1-to-S transition, thereby preventing its association with E2F transcription factors [111].